monoaluminum phosphate
Small moleculeexperimental
Kasal (Sodium Aluminum Phosphate, basic, non-leavening) is a white odorless powder comprised of an autogenous mixture of alkaline sodium aluminum phosphate and dibasic sodium phosphate. Kasal is used primarily as an emulsifier in the production of processed cheese. — NCATS
Clinical trial activity
5 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2006 (NCT00347555)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Loading structure…
SMILES
O=P([O-])([O-])[O-].[Al+3]- Mol. weight
- 121.95 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3833315 ↗
- NCATSF92V3S521O ↗
Also known as
- aluminium phosphate
- aluminium phosphate
- aluminium phosphate
- aluminum monophosphate
- aluminum phosphate
- aluminum phosphate
- aluminum phosphate
- aluminum phosphate
- aluminum phosphate (3:1)
- aluminum phosphate (3:2)
- aluminum phosphate dihydrate
- monoaluminum phosphate
- phosphalugel
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05559983 | Phase 1 | Nov 30, 2022 | EuBiologics Co.,Ltd, Harvard University, International Vaccine Institute |
| NCT02935686 | Phase 2 | Mar 31, 2017 | Janssen Pharmaceutica NV, Johnson and Johnson |
| NCT03165344 | N/A | Feb 10, 2017 | Peking University |
| NCT03026348 | Phase 2 | Jan 1, 2017 | Novavax |
| NCT00347555 | Phase 1 | May 1, 2006 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| EuBiologics Co.,Ltd | For profit | 1 | 0 | 1 | 2022 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| International Vaccine Institute | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Janssen Pharmaceutica NV | For profit | 1 | 0 | 1 | 2017 |
| Johnson and Johnson | For profit | 1 | 1 | 1 | 2017 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2006 |
| Novavax | For profit | 1 | 1 | 1 | 2017 |
| Peking University | Academic/Hospital | 1 | 1 | 1 | 2017 |
8 organizations
Page 1 / 1